Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust. Please let us know how you'd like ...
Once again, a life expectancy study has shown that HIV-positive people who start antiretroviral therapy (ART) promptly and have good access to medical care live as long as their HIV-negative peers.
Although well over half of new cases of HIV in the World Health Organization (WHO) European region (which includes Siberia and central Asia) occur in Russia, there is surprisingly little we know on a ...
A third of women living with HIV subtype C have a fall in their CD4 count to below 350 cells/mm 3 within a year of seroconversion, investigators report in the online edition of Clinical Infectious ...
Young men participating in a pre-exposure prophylaxis (PrEP) demonstration project experienced modest but significant bone loss after starting Truvada, according to findings presented yesterday to a ...
People with HIV in South Africa are ten times more likely to develop tuberculosis while interrupting treatment than while taking it, the 26th International AIDS Conference (AIDS 2026) in Rio de ...
With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
The 26th International AIDS Conference (AIDS 2026) in Rio de Janeiro, Brazil, featured few new scientific breakthroughs in terms of vaccines or cures for HIV. But as well as featuring two more cases ...
With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
A new class of drugs called CD4 mimetics could be used to sensitise the immune system to HIV, the 26th International AIDS Conference (AIDS 2026) in Rio de Janeiro heard last week. It is becoming clear ...